Korean J Dermatol.
2009 Apr;47(4):447-451.
A Case of Palmoplantar Hyperhidrosis Successfully Treated with Botulinum Toxin B
- Affiliations
-
- 1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. juhee@yuhs.ac
Abstract
- Hyperhidrosis is an eccrine sweat gland disease that results from sympathetic hyperactivity, usually occurring on the axilla, palm, sole, or groin. It causes not only cosmetic problems, but also social stress in affected patients. Until now, several modalities have been used to treat focal hyperhidrosis, with variable clinical outcomes and complications, including skin irritation, neurological problems, and nonesthetic scar formation. Botulinum toxin type A has been used widely and successfully in the treatment of hyperhidrosis since 1981. Botulinum toxin type B has recently been introduced for off-label use after being approved by the Food and Drug Administration in 2000 for the treatment of cervical dystonia. However, there has been no report of Botulinum toxin type B treatment for palmoplantar hyperhidrosis in the Koreandermatologic literature. Herein, we report the first case of palmoplantar hyperhidrosis successfully treated with Botulinum Toxin B in Korea, along with a review of the literature.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Botulinum A toxin for the treatment of focal hyperhidrosis: 5 cases
- Treatment of Winkles and Hyperhidrosis with Botulinum Toxin Type A
- Treatment of Compensatory Hyperhidrosis with Botulinum Toxin A: A case report
- Temporary Accommodation Difficulties after Botulinum Toxin Type B Injection for the Treatment of Hyperhidrosis
- The Changes of the Barrier Function of Axillary Skin and the Quality of Life in the Patients of Axillary Hyperhidrosis after the Injection of Botulinum Toxin A
